EFPIA Newsletter 31 March 2016

From our blog     31 March 2016 160331 Collaboration through IMI Could Render Ebola a Disease of the Past Magda Chlebus discusses how IMI is collaborating with key players in healthcare research... Read more →

Events Calendar     15 JUN 2016   160615 EFPIA Annual Conference 2016 Brussels, Belgium On 15 June 2016 at the Radisson Hotel Learn more →       05 APR 2016   160405 2016 China/EU Pharmaceutical Industry Forum Hamburg, Germany Focusing on the pharmaceutical market in China/EU Learn more →

	06 APR 2016			160406 DIA 28th Annual EuroMeeting 2016 Hamburg, Germany A platform to exchange ideas on key challenges facing healthcare Learn more →

	06 APR 2016			160406 ICH Info Day Hamburg, Germany Part of the pre-conference programme of the DIA EuroMeeting Learn more →

	13 APR 2016			160413 Biovision World Life Science Forum Lyon, France Dedicated to strengthening Action & Interaction for Innovation Learn more →

	13 APR 2016			160413 EFGCP Multi-Stakeholder Workshop Brussels, Belgium Discussion on how to ensure optimal ethical review within the new clinical trials regulation?... Learn more →

What we're reading Despite potential benefits, big data faces resistance in healthcare 31 March 2016  (Science Business) Read more → WHO downgrades Ebola health risk 31 March 2016  (BBC News) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe